Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1880 to 1929 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytidine deaminase (ec 3.5.4.5) (cytidine aminohydrolase). [source:swissprot;acc:p32320]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.852\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.225\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01074\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj850e9.1 (novel c2h2 type zinc finger protein similar to drosophila scratch (scrt), slug and xenopus snail) (fragment). [source:sptrembl;acc:q9nq03]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.592\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.355\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1882\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL28\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l28. [source:swissprot;acc:p46779]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.896\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0107\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1883\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PFKP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6-phosphofructokinase, type c (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme c) (pfk-c) (6-phosphofructokinase, platelet type). [source:swissprot;acc:q01813]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.317\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.881\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01067\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1884\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OLA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative gtp-binding protein ptd004 (pro2455). [source:swissprot;acc:q9ntk5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.081\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.373\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1885\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arginase 1 (ec 3.5.3.1) (liver-type arginase). [source:swissprot;acc:p05089]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.615\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01064\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1886\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arginase ii, mitochondrial precursor (ec 3.5.3.1) (non-hepatic arginase) (kidney-type arginase). [source:swissprot;acc:p78540]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.682\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01061\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1887\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SARM1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sterile alpha and tir motif containing 1; sterile alpha and heat/armadillo motif protein, ortholog of drosophila. [source:refseq;acc:nm\_015077]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.896\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.577\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1888\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ICT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
immature colon carcinoma transcript 1 (digestion substraction 1) (ds- 1). [source:swissprot;acc:q14197]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.414\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.131\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01056\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1889\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAB3IL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rab3a interacting protein (rabin3)-like 1. [source:refseq;acc:nm\_013401]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.067\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01054\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1890\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAB3IP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rab3a interacting protein isoform alpha 1; rabin3; ssx2 interacting protein. [source:refseq;acc:nm\_022456]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.314\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.111\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1891\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MCM3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna replication licensing factor mcm3 (dna polymerase alpha holoenzyme-associated protein p1) (rlf beta subunit) (p102 protein) (p1-mcm3). [source:swissprot;acc:p25205]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
233.828\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
231.395\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01051\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1892\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KEAP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kelch-like ech-associated protein 1 (cytosolic inhibitor of nrf2). [source:swissprot;acc:q14145]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1893\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GMPPB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gdp-mannose pyrophosphorylase b isoform 1; mannose-1-phosphate guanylyltransferase; amphoterin induced gene 3. [source:refseq;acc:nm\_013334]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.842\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
225.17\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01045\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1894\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GMPPA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gdp-mannose pyrophosphorylase a; mannose-1-phosphate guanylyltransferase (gdp). [source:refseq;acc:nm\_013335]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1895\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CAP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenylyl cyclase-associated protein 2 (cap 2). [source:swissprot;acc:p40123]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.853\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.639\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01036\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1896\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LDB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim domain binding 2; lim binding domain 2; lim domain-binding factor-2. [source:refseq;acc:nm\_001290]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
199.883\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
197.835\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01035\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1897\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1898\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LHX4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim/homeobox protein lhx4. [source:swissprot;acc:q969g2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.881\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
197.833\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1899\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LHX3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim/homeobox protein lhx3. [source:swissprot;acc:q9ubr4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
197.837\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1900\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC27A4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 4; fatty acid transport protein 4. [source:refseq;acc:nm\_005094]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.401\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.38\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01034\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1901\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TM7SF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
delta(14)-sterol reductase (ec 1.3.1.70) (c-14 sterol reductase) (sterol c14-reductase) (delta14-sr) (transmembrane 7 superfamily member 2) (another new gene 1) (putative sterol reductase sr-1). [source:swissprot;acc:o76062]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
191.411\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
193.39\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1902\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LBR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lamin b receptor (integral nuclear envelope inner membrane protein) (lmn2r). [source:swissprot;acc:q14739]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1903\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC27A3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 27 member 3; fatty acid transport protein 3. [source:refseq;acc:nm\_024330]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.385\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1904\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC27A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
very-long-chain acyl-coa synthetase (ec 6.2.1.-) (very-long-chain- fatty-acid-coa ligase). [source:swissprot;acc:o14975]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.424\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.404\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1905\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UTP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
disrupter of silencing 10. [source:refseq;acc:nm\_020368]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.411\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.39\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1906\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC27A6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
very long-chain acyl-coa synthetase homolog 1. [source:refseq;acc:nm\_014031]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.389\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1907\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC27A5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 5; very long-chain acyl-coa synthetase homolog 2; very long-chain acyl-coa synthetase-related protein; likely ortholog of mouse solute carrier family 27 (fatty acid transporter), member 5. [source:refseq;acc:nm\_012254]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.408\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.387\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1908\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIP2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to cg7020 gene product (fragment). [source:sptrembl;acc:q96ib4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.415\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.394\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1909\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CLGN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
calmegin precursor. [source:swissprot;acc:o14967]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.48\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
215.256\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01033\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1910\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CANX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
calnexin precursor (major histocompatibility complex class i antigen-binding protein p88) (p90) (ip90). [source:swissprot;acc:p27824]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1911\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEPSECS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
soluble liver antigen/liver pancreas antigen. [source:refseq;acc:nm\_153825]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1912\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RNMT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna (guanine-7-) methyltransferase. [source:refseq;acc:nm\_003799]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1913\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phospholipid scramblase 3 (pl scramblase 3) (ca(2+)-dependent phospholipid scramblase 3). [source:swissprot;acc:q9nry6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.745\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.564\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01021\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1914\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PLSCR4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phospholipid scramblase 4 (pl scramblase 4) (ca(2+)-dependent phospholipid scramblase 4). [source:swissprot;acc:q9nrq2]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1915\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PLSCR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phospholipid scramblase 2 (pl scramblase 2) (ca(2+)-dependent phospholipid scramblase 2). [source:swissprot;acc:q9nry7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.747\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.571\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01019\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1916\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHCG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rh type c glycoprotein. [source:refseq;acc:nm\_016321]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ING5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
p28 ing5. [source:refseq;acc:nm\_032329]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.848\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.039\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01015\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1918\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MED28\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
endothelial-derived gene 1. [source:refseq;acc:nm\_025205]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.211\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.18\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1919\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HARS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histidyl-trna synthetase homolog (ec 6.1.1.21) (histidine--trna ligase homolog) (hisrs). [source:swissprot;acc:p49590]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.349\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1920\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histidyl-trna synthetase (ec 6.1.1.21) (histidine--trna ligase) (hisrs). [source:swissprot;acc:p12081]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.413\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01013\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1921\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5-methyltetrahydrofolate--homocysteine methyltransferase (ec 2.1.1.13) (methionine synthase, vitamin-b12 dependent) (ms). [source:swissprot;acc:q99707]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.607\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.386\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01012\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1922\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
centaurin gamma 2. [source:swissprot;acc:q9upq3]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.659\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.452\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0101\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1923\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
USO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
general vesicular transport factor p115 (transcytosis associated protein) (tap) (vesicle docking protein). [source:swissprot;acc:o60763]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1924\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
centaurin gamma 1. [source:swissprot;acc:q99490]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1925\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
centaurin gamma 3. [source:swissprot;acc:q96p47]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1926\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHBG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rhesus blood group, b glycoprotein; rh type b glycoprotein. [source:refseq;acc:nm\_020407]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.925\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01008\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1927\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHAG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rhesus blood group-associated glycoprotein (erythrocyte plasma membrane 50 kda glycoprotein) (rh50a). [source:swissprot;acc:q02094]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.932\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.914\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01006\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1928\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
blood group rh(d) polypeptide (rhesus d antigen) (rhxiii) (rh polypeptide 2) (rhpii). [source:swissprot;acc:q02161]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.935\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01001\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1929\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
enigma protein; lim domain protein. [source:refseq;acc:nm\_005451]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.753\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.574\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/